Optigenex Enters Into License Agreement With Promethean

Optigenex has entered into a long term exclusive license agreement with Promethean for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11. AC-11 is a patented, all-natural rain forest botanical extract manufactured by Optigenex.

As per the new agreement, Promethean through its wholly owned subsidiary, Ceres Living is expected to market AIO Premium Cellular Health line of advanced dietary supplements, as well as specially formulated topical skin care products with AC-11.

Reportedly, the contract vests Promethean with exclusivity in the North American Direct Sales or Network Marketing distribution channel coinciding with the expiration of similar channel rights previously held by former licensee.

In addition to North American Direct Sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.

Matthew Henninger, chairman and CEO of Promethean, said: “We had wanted to work with the Optigenex team and their product AC-11 since before we developed the AIO Premium Cellular Health product line. Now that timing has allowed our two companies to align, we look forward to continued collaborative research and development of products that offer the best technologies in cellular health and nutrition.”